Cargando…
COVID-19 vaccine preferences in India()
India’s mass vaccination efforts have been slow due to high levels of vaccine hesitancy. This study uses data from an online discrete choice experiment with 1371 respondents to rigorously examine the factors shaping vaccine preference in the country. We find that vaccine efficacy, presence of side e...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898737/ https://www.ncbi.nlm.nih.gov/pubmed/35282928 http://dx.doi.org/10.1016/j.vaccine.2022.02.077 |
_version_ | 1784663724892618752 |
---|---|
author | Bansal, Prateek Raj, Alok Mani Shukla, Dhirendra Sunder, Naveen |
author_facet | Bansal, Prateek Raj, Alok Mani Shukla, Dhirendra Sunder, Naveen |
author_sort | Bansal, Prateek |
collection | PubMed |
description | India’s mass vaccination efforts have been slow due to high levels of vaccine hesitancy. This study uses data from an online discrete choice experiment with 1371 respondents to rigorously examine the factors shaping vaccine preference in the country. We find that vaccine efficacy, presence of side effects, protection duration, distance to vaccination centre and vaccination rates within social network play a critical role in determining vaccine demand. We apply a non-parametric model to uncover heterogeneity in the effects of these factors. We derive two novel insights from this analysis. First, even though, on average, domestically developed vaccines are preferred, around 30% of the sample favours foreign-developed vaccines. Second, vaccine preference of around 15% of the sample is highly sensitive to the presence of side effects and vaccination uptake among their peer group. These results provide insights for the ongoing policy debate around vaccine adoption in India. |
format | Online Article Text |
id | pubmed-8898737 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88987372022-03-07 COVID-19 vaccine preferences in India() Bansal, Prateek Raj, Alok Mani Shukla, Dhirendra Sunder, Naveen Vaccine Short Communication India’s mass vaccination efforts have been slow due to high levels of vaccine hesitancy. This study uses data from an online discrete choice experiment with 1371 respondents to rigorously examine the factors shaping vaccine preference in the country. We find that vaccine efficacy, presence of side effects, protection duration, distance to vaccination centre and vaccination rates within social network play a critical role in determining vaccine demand. We apply a non-parametric model to uncover heterogeneity in the effects of these factors. We derive two novel insights from this analysis. First, even though, on average, domestically developed vaccines are preferred, around 30% of the sample favours foreign-developed vaccines. Second, vaccine preference of around 15% of the sample is highly sensitive to the presence of side effects and vaccination uptake among their peer group. These results provide insights for the ongoing policy debate around vaccine adoption in India. Elsevier Ltd. 2022-04-01 2022-03-07 /pmc/articles/PMC8898737/ /pubmed/35282928 http://dx.doi.org/10.1016/j.vaccine.2022.02.077 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Bansal, Prateek Raj, Alok Mani Shukla, Dhirendra Sunder, Naveen COVID-19 vaccine preferences in India() |
title | COVID-19 vaccine preferences in India() |
title_full | COVID-19 vaccine preferences in India() |
title_fullStr | COVID-19 vaccine preferences in India() |
title_full_unstemmed | COVID-19 vaccine preferences in India() |
title_short | COVID-19 vaccine preferences in India() |
title_sort | covid-19 vaccine preferences in india() |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898737/ https://www.ncbi.nlm.nih.gov/pubmed/35282928 http://dx.doi.org/10.1016/j.vaccine.2022.02.077 |
work_keys_str_mv | AT bansalprateek covid19vaccinepreferencesinindia AT rajalok covid19vaccinepreferencesinindia AT manishukladhirendra covid19vaccinepreferencesinindia AT sundernaveen covid19vaccinepreferencesinindia |